PROHANCE
PROHANCE
Approved
DIN Number
02229056
Drug Class
Human
Market Date
Sep 8, 1998
Company
HC
E-Z-Em Canada Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02229056
AIG Number0124199001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA04 GADOTERIDOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification
ACTIVE INGREDIENTS (1)
GADOTERIDOLActive
Strength: 279.3 MG / ML
Monograph: GADOTERIDOL